Regulatory Disclosure
Manipal Health Enterprises Limited (formerly Manipal Health Enterprises Private Limited) submitted a press release disclosure to National Stock Exchange of India Limited (NSE Scrip Symbol: MANIPALHOS) and BSE Limited (BSE Scrip Code: 544847) on September 18, 2026, pursuant to Regulation 30 of SEBI Listing Regulations.
Event Details
Manipal Health Enterprises Limited has fully redeemed outstanding listed non-convertible debentures (NCDs) of nominal value ₹5,310 crore issued by its wholly owned subsidiary, Manipal Hospitals Private Limited. The redemption was completed using the relevant portion of the IPO proceeds, in accordance with the objects of the Initial Public Offering disclosed in the Prospectus dated July 31, 2026.
Financial Details
The redemption includes the outstanding NCD principal amount along with accrued interest and applicable prepayment/early redemption costs. The company stated this move marks a key step in its post-listing financial strategy and is expected to strengthen its balance sheet and improve financial leverage.
Management Commentary
Sameer Agarwal, Chief Financial Officer of Manipal Health Enterprises Limited, stated: "The full redemption of ₹5,310 crore of NCDs is an important milestone in our post-listing journey. By deploying the IPO proceeds towards debt repayment as planned, we are strengthening our balance sheet, reducing our interest burden and creating greater financial headroom to support our growth plans. This gives us greater flexibility to continue investing in capacity, technology and talent while remaining focused on delivering quality and affordable healthcare."
Operational Impact
The debt reduction is expected to support the company's focus on profitable growth and operational efficiency, while providing greater financial flexibility for its ongoing expansion and investment priorities.
Q1 FY27 Performance Update
The announcement follows Manipal Health's strong Q1 FY27 performance, with revenue growing 38.1% year-on-year to ₹3,091 crore and EBITDA rising 26.4% to ₹749 crore. PAT stood at ₹243 crore, while adjusted PAT grew 30.9% to ₹332 crore.
Strategic Rationale
The redemption is in line with the stated objects of the IPO and reflects the company's focus on disciplined capital allocation and strengthening its financial position as it enters its next phase of growth.
Company Background
Manipal Hospitals is one of India's leading integrated healthcare providers with a pan-India network of 50 multispecialty hospitals and over 13,000 licensed beds across 14 states and union territories. The network is the country's largest multispecialty hospital network by bed capacity, supported by more than 11,000 doctors and 25,000 employees. The company serves over 7 million patients annually and holds NABH and AAHRPP accreditations.